Castleark Management LLC Heron Therapeutics, Inc. Transaction History

Castleark Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$22.03 - $32.01 $1.93 Million - $2.81 Million	-87,660 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$30.0 - $40.85 $3.4 Million - $4.63 Million	-113,420 Reduced 56.41%	87,660 $2.77 Million
Q2 2018 Aug 15, 2018	BUY	$26.4 - $42.0 $3.74 Million - $5.94 Million	141,505 Added 237.52%	201,080 $7.81 Million
Q1 2018 May 15, 2018	BUY	$18.43 - $28.8 $1.1 Million - $1.72 Million	59,575 New	59,575 $1.64 Million

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.